Ascendis Pharma A/S (ASND): Price and Financial Metrics

Ascendis Pharma A/S (ASND)

Today's Latest Price: $136.03 USD

0.23 (0.17%)

Updated Jan 27 4:00pm

Add ASND to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 330 in Biotech

See all "A" rated Strong Buy stocks

ASND Stock Summary

  • The ratio of debt to operating expenses for Ascendis Pharma A is higher than it is for about merely 0.37% of US stocks.
  • With a price/sales ratio of 487.8, Ascendis Pharma A has a higher such ratio than 99.3% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, Ascendis Pharma A is reporting a growth rate of 1,247.11%; that's higher than 98.93% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Ascendis Pharma A are PRNB, ACIU, MGNX, ARGX, and MRTX.
  • ASND's SEC filings can be seen here. And to visit Ascendis Pharma A's official web site, go to
ASND Daily Price Range
ASND 52-Week Price Range

ASND Stock Price Chart More Charts

ASND Price/Volume Stats

Current price $136.03 52-week high $142.94
Prev. close $135.80 52-week low $66.11
Day low $132.93 Volume 99,462
Day high $137.05 Avg. volume 210,374
50-day MA $124.99 Dividend yield N/A
200-day MA $115.97 Market Cap 5.73B

Ascendis Pharma A/S (ASND) Company Bio

Ascendis Pharma A/S is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best-in-class therapeutics that address significant unmet medical needs. The company was founded in 2006 and is based in Hellerup, Denmark.

ASND Latest News Stream

Event/Time News Detail
Loading, please wait...

ASND Latest Social Stream

Loading social stream, please wait...

View Full ASND Social Stream

ASND Price Returns

1-mo 0.71%
3-mo 24.80%
6-mo 17.51%
1-year 84.52%
3-year 542.86%
5-year 622.41%
YTD -2.22%
2019 122.06%
2018 56.39%
2017 97.92%
2016 10.48%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6162 seconds.